Compare RDHL & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RDHL | GXAI |
|---|---|---|
| Founded | 2009 | 2021 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 8.8M |
| IPO Year | N/A | 2023 |
| Metric | RDHL | GXAI |
|---|---|---|
| Price | $1.18 | $1.07 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 69.2K | ★ 79.0K |
| Earning Date | 09-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,550,000.00 | $694,278.00 |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 157.62 | ★ 23205.74 |
| 52 Week Low | $1.01 | $1.00 |
| 52 Week High | $7.00 | $3.77 |
| Indicator | RDHL | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 47.48 | 33.94 |
| Support Level | $1.15 | $1.07 |
| Resistance Level | $1.24 | $1.30 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 33.66 | 8.08 |
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.